Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. MCCLOSKEY WW
   USE OF INTRAVENOUS INOTROPIC THERAPY IN THE HOME
   American journal of health-system pharmacy
   
   W.W. Mccloskey, "USE OF INTRAVENOUS INOTROPIC THERAPY IN THE HOME", American journal of health-system pharmacy, 55(9), 1998, pp. 930-935
2. FERRARI RP; LAURENTI E; GHIBAUDI EM; GAMBINO O
   ESR CHARACTERIZATION KINETICS OF THE ENZYMATICALLY OBTAINED M(II)-DOBUTAMINE-O-SEMIQUINONE SYSTEM
   Research of chemical intermediates
   
   R.P. Ferrari et al., "ESR CHARACTERIZATION KINETICS OF THE ENZYMATICALLY OBTAINED M(II)-DOBUTAMINE-O-SEMIQUINONE SYSTEM", Research of chemical intermediates, 22(5), 1996, pp. 459-468
3. LAM XM; WARD CA; DUMEE CPRD
   STABILITY AND ACTIVITY OF ALTEPLASE WITH INJECTABLE DRUGS COMMONLY USED IN CARDIAC THERAPY
   American journal of health-system pharmacy
   
   X.M. Lam et al., "STABILITY AND ACTIVITY OF ALTEPLASE WITH INJECTABLE DRUGS COMMONLY USED IN CARDIAC THERAPY", American journal of health-system pharmacy, 52(17), 1995, pp. 1904-1909
4. HASSAN E; LESLIE J; MARTIRHERRERO ML
   STABILITY OF LABETALOL HYDROCHLORIDE WITH SELECTED CRITICAL CARE DRUGS DURING SIMULATED Y-SITE INJECTION
   American journal of hospital pharmacy
   
   E. Hassan et al., "STABILITY OF LABETALOL HYDROCHLORIDE WITH SELECTED CRITICAL CARE DRUGS DURING SIMULATED Y-SITE INJECTION", American journal of hospital pharmacy, 51(17), 1994, pp. 2143-2145